{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T16:24:15Z","timestamp":1784132655429,"version":"3.55.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005349","name":"Socialstyrelsen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ijid.2025.108156","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T19:34:52Z","timestamp":1761593692000},"page":"108156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Risk factors for hospitalization and death due to COVID-19 during endemic Omicron circulation, a population-based cohort study"],"prefix":"10.1016","volume":"161","author":[{"given":"Ulrika","family":"Marking","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Wahlstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Holm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sten","family":"Walther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e5kan","family":"Hanberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristoffer","family":"Str\u00e5lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2025.108156_bib0001","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0140-6736(22)00017-4","article-title":"Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study","volume":"399","author":"Wolter","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2025.108156_bib0002","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S1473-3099(22)00154-2","article-title":"Risk of hospitalisation associated with infection with SARS-CoV-2 omicron variant versus delta variant in Denmark: an observational cohort study","volume":"22","author":"Bager","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2025.108156_bib0003","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0140-6736(22)00462-7","article-title":"Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study","volume":"399","author":"Nyberg","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2025.108156_bib0004","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1038\/s41591-022-01887-z","article-title":"Clinical outcomes associated with SARS-CoV-2 Omicron (B.1.1.529) variant and BA.1\/BA.1.1 or BA.2 subvariant infection in Southern California","volume":"28","author":"Lewnard","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.ijid.2025.108156_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiph.2024.102502","article-title":"Severity outcomes of SARS-CoV-2 infection in the Omicron and pre-Omicron periods, in unvaccinated first-time test positive adults less than 65 years old without comorbidity, in Sweden","volume":"17","author":"Wahlstr\u00f6m","year":"2024","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.ijid.2025.108156_bib0006","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41586-022-04479-6","article-title":"SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo","volume":"603","author":"Hui","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ijid.2025.108156_bib0007","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/s41586-022-04462-1","article-title":"Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant","volume":"603","author":"Suzuki","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ijid.2025.108156_bib0008","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/pds.1294","article-title":"The new Swedish Prescribed Drug Register\u2013opportunities for pharmacoepidemiological research and experience from the first six months","volume":"16","author":"Wettermark","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.ijid.2025.108156_bib0009","unstructured":"National Board of Health and Welfare. Statistical register\u2019s producion and quality - National Prescribed Drug Register. Version 1, Item no.: 2021-9-7548, https:\/\/www.socialstyrelsen.se\/globalassets\/sharepoint-dokument\/dokument-webb\/ovrigt\/production-and-quality-lmed.pdf, 2021."},{"key":"10.1016\/j.ijid.2025.108156_bib0010","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2147\/CLEP.S282475","article-title":"Adaptation of the Charlson comorbidity index for register-based research in Sweden","volume":"13","author":"Ludvigsson","year":"2021","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.ijid.2025.108156_bib0011","unstructured":"European Center for Disease Prevention and Control. COVID-19 vaccine tracker, https:\/\/vaccinetracker.ecdc.europa.eu\/public\/extensions\/COVID-19\/vaccine-tracker.html#uptake-tab; n.d. [accessed 24 April 2025]."},{"key":"10.1016\/j.ijid.2025.108156_bib0012","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0290221","article-title":"Predicting clinical outcomes of SARS-CoV-2 infection during the Omicron wave using machine learning","volume":"19","author":"Cogill","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2025.108156_bib0013","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-072976","article-title":"Risk prediction of Covid-19 related death or hospital admission in adults testing positive for SARS-CoV-2 infection during the omicron wave in England (QCOVID4): cohort study","volume":"381","author":"Hippisley-Cox","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.ijid.2025.108156_bib0014","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1080\/23744235.2025.2465828","article-title":"60-day mortality and the role of SARS-CoV-2 in hospital admissions of immunocompromised patients during later Omicron period: a population-based study in Sweden","volume":"57","author":"Spreco","year":"2025","journal-title":"Infect Dis (Lond)"},{"key":"10.1016\/j.ijid.2025.108156_bib0015","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/03007995.2024.2442515","article-title":"Assessment of clinical characteristics and mortality in patients hospitalized with SARS-CoV-2 from January 2022 to November 2022, when Omicron variants were predominant in the United States","volume":"41","author":"Scott","year":"2025","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.ijid.2025.108156_bib0016","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/jamaoncol.2023.5042","article-title":"Mortality and hospitalization risks in patients with cancer and the SARS-CoV-2 omicron variant","volume":"10","author":"Ofer","year":"2024","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ijid.2025.108156_bib0017","article-title":"COVID-19 and multiple sclerosis: challenges and lessons for patient care","volume":"44","author":"Prosperini","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.ijid.2025.108156_bib0018","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/acr2.11386","article-title":"Coronavirus disease 2019 outcomes among recipients of anti-CD20 monoclonal antibodies for immune-mediated diseases: a comparative cohort study","volume":"4","author":"Patel","year":"2022","journal-title":"ACR Open Rheumatol"},{"key":"10.1016\/j.ijid.2025.108156_bib0019","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1016\/S2665-9913(23)00004-8","article-title":"Breakthrough SARS-CoV-2 infections and prediction of moderate-to-severe outcomes during rituximab therapy in patients with rheumatic and musculoskeletal diseases in the UK: a single-centre cohort study","volume":"5","author":"Md Yusof","year":"2023","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.ijid.2025.108156_bib0020","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1265\/ehpm.23-00274","article-title":"Risk of severe COVID-19 in unvaccinated patients during the period from wild-type to Omicron variant: real-world evidence from Japan","volume":"29","author":"Tomioka","year":"2024","journal-title":"Environ Health Prev Med"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971225003789?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971225003789?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T13:03:47Z","timestamp":1780664627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971225003789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":20,"alternative-id":["S1201971225003789"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2025.108156","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors for hospitalization and death due to COVID-19 during endemic Omicron circulation, a population-based cohort study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2025.108156","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"108156"}}